Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | WX-0593 |
Trade Name | |
Synonyms | WX0593|WX 0593|FL 006|FL-006|FL006|Iruplinalkib |
Drug Descriptions |
WX-0593 (iruplinalkib) inhibits ALK and ROS1, with additional activity against EGFR mutations, which may lead to decreased tumor growth (PMID: 35087031; Cancer Res 2018;78(13 Suppl):Abstract nr 4794). |
DrugClasses | ALK Inhibitor 29 EGFR Inhibitor (Pan) 55 ROS1 Inhibitor 19 |
CAS Registry Number | NA |
NCIT ID | C154279 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Panitumumab + WX-0593 | Panitumumab WX-0593 | 0 | 0 |
QL1203 + WX-0593 | QL1203 WX-0593 | 0 | 0 |
WX-0593 | WX-0593 | 18 | 0 |